Infectious Diseases and Clinical Microbiology

Prof. Dr. Reşit Mıstık

Doctor and researcher Medicana Bursa Bursa
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicana.com.tr.

  • Virüs Hepatitleri
  • AIDS
  • Bağışıklığı Baskılanmış Hastalardaki Enfeksiyonlar (Hematoloji- Onkoloji Hastaları) ve Toplumda Kazanılmış Enfeksiyonlar

CV

Education and experience

From source

Experience

  • Experience8 Yıl Serbest Hekimlik, 32 yıl Uludağ Üniversitesi Tıp Fakültesimedicana.com.tr

Education

  • 1975İstanbul Üniversitesi Cerrahpaşa Tıp Fakmedicana.com.tr
  • 1989Uludağ Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıklar ve Klinik Mikrobiyoloji A.D.medicana.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologymedicana.com.trFrom source
  • Department name at the sourceEnfeksiyon Hastalıklarımedicana.com.trFrom source
  • InstitutionMedicana Bursamedicana.com.trFrom source
  • Publications32 publicationsmedicana.com.tr profile pageFrom source
  • Last synchronised7 November 2026 03:21https://www.medicana.com.tr/hekim-detay/5909/resit-mistikmedicana.com.tr

Scientific work

Publications

32 publications

  1. Özvatan TŞ, Koçak C, Alver O, Mıstık R, Aslan E.

    Source: medicana.com.tr profile page

  2. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

    Source: medicana.com.tr profile page

  3. Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators.

    Source: medicana.com.tr profile page

  4. N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.

    Source: medicana.com.tr profile page

  5. 2-Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C.

    Source: medicana.com.tr profile page

  6. Sargin Altunok E, Sayan M, Akhan S, Aygen B, Yildiz O, Tekin Koruk S, Mistik R, Demirturk N, Ural O, Kose Ş, Aynioglu A, Korkmaz F, Ersoz G, Tuna N, Ayaz C, Karakecili F, Keten D, Inan D, Yazici S, Koculu S, Yildirmak T.

    Source: medicana.com.tr profile page

  7. Int J Infect Dis. 2016 Sep;50:1-5. doi: 10.1016/j.ijid.2016.07.003. Epub 2016 Jul 9.

    Source: medicana.com.tr profile page

  8. 3-Brucellosis: a retrospective evaluation of 164 cases.

    Source: medicana.com.tr profile page

  9. Kazak E, Akalın H, Yılmaz E, Heper Y, Mıstık R, Sınırtaş M, Özakın C, Göral G, Helvacı S.

    Source: medicana.com.tr profile page

  10. Singapore Med J. 2016 Nov;57(11):624-629. doi: 10.11622/smedj.2015163. Epub 2015 Nov 13.

    Source: medicana.com.tr profile page

View all 32 publications